Last: | $2.74 |
---|---|
Change Percent: | -0.94% |
Open: | $2.15 |
Close: | $2.74 |
High: | $3.7 |
Low: | $2.0912 |
Volume: | 478,449 |
Last Trade Date Time: | 09/25/2023 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.74 | $2.15 | $2.74 | $3.7 | $2.0912 | 478,449 | 09-25-2023 |
$2.13 | $2.31 | $2.13 | $2.5 | $1.97 | 5,000 | 09-22-2023 |
$2.34 | $2.12 | $2.34 | $2.4 | $2.12 | 9,207 | 09-21-2023 |
$2.21 | $2.02 | $2.21 | $2.21 | $2.02 | 6,551 | 09-20-2023 |
$2.08 | $2.09 | $2.08 | $2.12 | $2.0493 | 7,816 | 09-19-2023 |
$2.1 | $2.1 | $2.1 | $2.1908 | $2 | 22,277 | 09-18-2023 |
$2.12 | $2.22 | $2.12 | $2.3282 | $2.07 | 19,434 | 09-15-2023 |
$2.14 | $2.22 | $2.14 | $2.4 | $2.11 | 14,989 | 09-14-2023 |
$2.24 | $2.37 | $2.24 | $2.45 | $2.2 | 23,544 | 09-13-2023 |
$2.42 | $2.63 | $2.42 | $2.73 | $2.3102 | 66,886 | 09-12-2023 |
$2.85 | $3.7 | $2.85 | $3.7 | $2.81 | 152,788 | 09-11-2023 |
$3.62 | $3.83 | $3.62 | $4.38 | $3.5335 | 169,132 | 09-08-2023 |
$4.95 | $3.66 | $4.95 | $4.96 | $3.4205 | 479,577 | 09-07-2023 |
$3.63 | $3.98 | $3.63 | $4.31 | $3.51 | 112,882 | 09-06-2023 |
$4.06 | $4.05 | $4.06 | $4.45 | $3.67 | 163,777 | 09-05-2023 |
$4.21 | $3.77 | $4.21 | $4.69 | $3.3108 | 355,055 | 09-04-2023 |
$4.21 | $3.77 | $4.21 | $4.69 | $3.3108 | 355,055 | 09-01-2023 |
$3.8 | $3.25 | $3.8 | $4.67 | $3.18 | 265,762 | 08-31-2023 |
$3.29 | $3.65 | $3.29 | $3.6999 | $3.14 | 65,171 | 08-30-2023 |
$3.79 | $3.81 | $3.79 | $5.0101 | $3.6874 | 335,206 | 08-29-2023 |
News, Short Squeeze, Breakout and More Instantly...
Digital Media Solutions Inc. Class A Company Name:
DMS Stock Symbol:
NYSE Market:
Delisting does not affect the Company’s day to day business operations or its relationships with partners or employees DMS will continue as a public company The Company’s Class A common stock is expected to continue to trade on the over-the-counter markets CLEARWATER...
Gainers Biocept, Inc. (NASDAQ: BIOC) shares jumped 97.6% to $1.6608 after the company announced non-exclusive licensing agreement for CNSide with...
Gainers Impel Pharmaceuticals Inc. (NASDAQ: IMPL) rose 41.3% to $0.54 in pre-market trading after falling 4% on Thursday. AGBA Group Holding Limit...